A scientific advisory panel to the EPA is convening today to evalute the environmental watchdog’s determination that a common medical device sterilizer, ethylene oxide, is carcinogenic.
If the panel confirms that assessment, medtech companies warn, it could disrupt the supply chain for their lifesaving products.
A trio of medical device makers collected Pentagon supply deals worth a collective $234.3 million, according to recent Defense Dept. reports.
Medical Action Industries (NSDQ:MDCI) said it inked a deal with Inteplast Group’s Medira Inc. to sell its Medegen Medical Products subsidiary for $75 million.
SafeShot Technologies said it brought in a $6 million funding round to pursue a new business strategy, relocated to the Reprise Technologies medical device incubator and expanded its executive roster.
Now based out of the Reprise facilities in Menlo Park, Calif., SafeShot plans to "execute its new business strategy aimed at filling the gap in the supply of sterile injectable medications," according to a press release.
Baird Capital invested in the Chinese medical device supplier Kedu Healthcare, sending over a new board member as part of the deal. The healthcare investment firm kept quiet about the amount of cash involved in the deal.
McKesson (NYSE:MCK) agreed to pay $29 per share for PSS World Medical (NSDQ:PSSI) and its medical supplies business in a deal worth $2.1 billion.
MassDevice Network
@MassDevice
LinkedIn
YouTube